User: Guest

MRSA DRUGS

Global Market Trajectory & Analytics

MCP13488

VALIDATED EXECUTIVE ENGAGEMENTS

POOL + OUTREACH

3647
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

656
Interactions with Platform & by Email

PARTICIPANTS

109
Unique # Participated

VALIDATIONS

49
Responses Validated*
* Login to view program details and full enterprise executive list.

DATE

JULY 2020

TABLES

108

PAGES

179

EDITION

7

PRICE

USD $4950


Amid the COVID-19 crisis, the global market for MRSA Drugs estimated at US$3.1 Billion in the year 2020, is projected to reach a revised size of US$3.8 Billion by 2027, growing at a CAGR of 3% over the analysis period 2020-2027. Lipopeptide, one of the segments analyzed in the report, is projected to record a 1.7% CAGR and reach US$1.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Oxazolidinone segment is readjusted to a revised 4.6% CAGR for the next 7-year period.
The MRSA Drugs market in the U.S. is estimated at US$905.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$678.6 Million by the year 2027 trailing a CAGR of 2.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 2.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.
In the global Cephalosporin segment, USA, Canada, Japan, China and Europe will drive the 4.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$359.3 Million in the year 2020 will reach a projected size of US$487.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$424.6 Million by the year 2027.We bring years of research experience to this 7th edition of our report. The 179-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Absynth Biologics; Allergan PLC; AmpliPhi Biosciences Corporation; AstraZeneca PLC; Basilea Pharmaceutica Ltd.; Baxter International, Inc.; Cempra, Inc.; CrystalGenomics Inc.; Debiopharm Group; Galapagos NV; GlaxoSmithKline plc; Innovation Pharmaceuticals Inc.; Kyorin Pharmaceutical Co., Ltd.; Lytix Biopharma AS; Melinta Therapeutics, Inc.; Merck & Co., Inc.; Nabriva Therapeutics US, Inc.; NovaDigm Therapeutics, Inc.; Paratek Pharmaceuticals, Inc.; Pfizer, Inc.; R-Pharm-US LLC; Savara Inc.; Sealife PHARMA GMBH; Sequella, Inc.; The Medicines Company; Theravance Biopharma, Inc. ; XBiotech Inc.
» Drug Class (Lipopeptide, Oxazolidinone, Cephalosporin, Tetracycline, Other Drug Classes) » Route of Administration (Oral, Parenteral)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

ACTIVE CLIENT

INACTIVE CLIENT

ACTIVE PANELIST

INACTIVE PANELIST

OPT-INS

FEATURED COMPANIES

Registration is required to access our data stacks.

WORLD BRANDS

Registration is required to access our data stacks.

EXECUTIVES ENGAGED

Registration is required to access our data stacks.

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

  
05
1. MARKET OVERVIEW
Global Competitor Market Shares
MRSA Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
MRSA Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
MRSA Drugs Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
MRSA Drugs Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
Lipopeptide (Drug Class) World Market by Region/Country in US$ Million: 2020 to 2027
Lipopeptide (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
Lipopeptide (Drug Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
Oxazolidinone (Drug Class) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
Oxazolidinone (Drug Class) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
Oxazolidinone (Drug Class) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
Cephalosporin (Drug Class) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
Cephalosporin (Drug Class) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
Cephalosporin (Drug Class) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
Tetracycline (Drug Class) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
Tetracycline (Drug Class) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
Tetracycline (Drug Class) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
Other Drug Classes (Drug Class) World Market by Region/Country in US$ Million: 2020 to 2027
Other Drug Classes (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
Other Drug Classes (Drug Class) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
Oral (Route of Administration) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027
Oral (Route of Administration) Market Worldwide Historic Review by Region/Country in US$ Million: 2012 to 2019
Oral (Route of Administration) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS 2027
Parenteral (Route of Administration) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to 2027
Parenteral (Route of Administration) Global Historic Demand in US$ Million by Region/Country: 2012 to 2019
Parenteral (Route of Administration) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US MRSA Drugs Market Share (in %) by Company: 2019 & 2025
United States MRSA Drugs Market Estimates and Projections in US$ Million by Drug Class: 2020 to 2027
MRSA Drugs Market in the United States by Drug Class: A Historic Review in US$ Million for 2012-2019
United States MRSA Drugs Market Share Breakdown by Drug Class: 2012 VS 2020 VS 2027
United States MRSA Drugs Market Estimates and Projections in US$ Million by Route of Administration: 2020 to 2027
MRSA Drugs Market in the United States by Route of Administration: A Historic Review in US$ Million for 2012-2019
United States MRSA Drugs Market Share Breakdown by Route of Administration: 2012 VS 2020 VS 2027
CANADA
Canadian MRSA Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2020 to 2027
Canadian MRSA Drugs Historic Market Review by Drug Class in US$ Million: 2012-2019
MRSA Drugs Market in Canada: Percentage Share Breakdown of Sales by Drug Class for 2012, 2020, and 2027
Canadian MRSA Drugs Market Estimates and Forecasts in US$ Million by Route of Administration: 2020 to 2027
Canadian MRSA Drugs Historic Market Review by Route of Administration in US$ Million: 2012-2019
MRSA Drugs Market in Canada: Percentage Share Breakdown of Sales by Route of Administration for 2012, 2020, and 2027
JAPAN
Japanese Market for MRSA Drugs: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2020-2027
MRSA Drugs Market in Japan: Historic Sales Analysis in US$ Million by Drug Class for the Period 2012-2019
Japanese MRSA Drugs Market Share Analysis by Drug Class: 2012 VS 2020 VS 2027
Japanese Market for MRSA Drugs: Annual Sales Estimates and Projections in US$ Million by Route of Administration for the Period 2020-2027
MRSA Drugs Market in Japan: Historic Sales Analysis in US$ Million by Route of Administration for the Period 2012-2019
Japanese MRSA Drugs Market Share Analysis by Route of Administration: 2012 VS 2020 VS 2027
CHINA
Chinese MRSA Drugs Market Growth Prospects in US$ Million by Drug Class for the Period 2020-2027
MRSA Drugs Historic Market Analysis in China in US$ Million by Drug Class: 2012-2019
Chinese MRSA Drugs Market by Drug Class: Percentage Breakdown of Sales for 2012, 2020, and 2027
Chinese MRSA Drugs Market Growth Prospects in US$ Million by Route of Administration for the Period 2020-2027
MRSA Drugs Historic Market Analysis in China in US$ Million by Route of Administration: 2012-2019
Chinese MRSA Drugs Market by Route of Administration: Percentage Breakdown of Sales for 2012, 2020, and 2027
EUROPE
Market Facts & Figures
European MRSA Drugs Market: Competitor Market Share Scenario (in %) for 2019 & 2025
European MRSA Drugs Market Demand Scenario in US$ Million by Region/Country: 2020-2027
MRSA Drugs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
European MRSA Drugs Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
European MRSA Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2020-2027
MRSA Drugs Market in Europe in US$ Million by Drug Class: A Historic Review for the Period 2012-2019
European MRSA Drugs Market Share Breakdown by Drug Class: 2012 VS 2020 VS 2027
European MRSA Drugs Market Estimates and Forecasts in US$ Million by Route of Administration: 2020-2027
MRSA Drugs Market in Europe in US$ Million by Route of Administration: A Historic Review for the Period 2012-2019
European MRSA Drugs Market Share Breakdown by Route of Administration: 2012 VS 2020 VS 2027
FRANCE
MRSA Drugs Market in France by Drug Class: Estimates and Projections in US$ Million for the Period 2020-2027
French MRSA Drugs Historic Market Scenario in US$ Million by Drug Class: 2012-2019
French MRSA Drugs Market Share Analysis by Drug Class: 2012 VS 2020 VS 2027
MRSA Drugs Market in France by Route of Administration: Estimates and Projections in US$ Million for the Period 2020-2027
French MRSA Drugs Historic Market Scenario in US$ Million by Route of Administration: 2012-2019
French MRSA Drugs Market Share Analysis by Route of Administration: 2012 VS 2020 VS 2027
GERMANY
MRSA Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2020-2027
German MRSA Drugs Historic Market Analysis in US$ Million by Drug Class: 2012-2019
German MRSA Drugs Market Share Breakdown by Drug Class: 2012 VS 2020 VS 2027
MRSA Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Route of Administration for the Period 2020-2027
German MRSA Drugs Historic Market Analysis in US$ Million by Route of Administration: 2012-2019
German MRSA Drugs Market Share Breakdown by Route of Administration: 2012 VS 2020 VS 2027
ITALY
Italian MRSA Drugs Market Growth Prospects in US$ Million by Drug Class for the Period 2020-2027
MRSA Drugs Historic Market Analysis in Italy in US$ Million by Drug Class: 2012-2019
Italian MRSA Drugs Market by Drug Class: Percentage Breakdown of Sales for 2012, 2020, and 2027
Italian MRSA Drugs Market Growth Prospects in US$ Million by Route of Administration for the Period 2020-2027
MRSA Drugs Historic Market Analysis in Italy in US$ Million by Route of Administration: 2012-2019
Italian MRSA Drugs Market by Route of Administration: Percentage Breakdown of Sales for 2012, 2020, and 2027
UNITED KINGDOM
United Kingdom Market for MRSA Drugs: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2020-2027
MRSA Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Drug Class for the Period 2012-2019
United Kingdom MRSA Drugs Market Share Analysis by Drug Class: 2012 VS 2020 VS 2027
United Kingdom Market for MRSA Drugs: Annual Sales Estimates and Projections in US$ Million by Route of Administration for the Period 2020-2027
MRSA Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Route of Administration for the Period 2012-2019
United Kingdom MRSA Drugs Market Share Analysis by Route of Administration: 2012 VS 2020 VS 2027
REST OF EUROPE
Rest of Europe MRSA Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2020-2027
MRSA Drugs Market in Rest of Europe in US$ Million by Drug Class: A Historic Review for the Period 2012-2019
Rest of Europe MRSA Drugs Market Share Breakdown by Drug Class: 2012 VS 2020 VS 2027
Rest of Europe MRSA Drugs Market Estimates and Forecasts in US$ Million by Route of Administration: 2020-2027
MRSA Drugs Market in Rest of Europe in US$ Million by Route of Administration: A Historic Review for the Period 2012-2019
Rest of Europe MRSA Drugs Market Share Breakdown by Route of Administration: 2012 VS 2020 VS 2027
ASIA-PACIFIC
MRSA Drugs Market in Asia-Pacific by Drug Class: Estimates and Projections in US$ Million for the Period 2020-2027
Asia-Pacific MRSA Drugs Historic Market Scenario in US$ Million by Drug Class: 2012-2019
Asia-Pacific MRSA Drugs Market Share Analysis by Drug Class: 2012 VS 2020 VS 2027
MRSA Drugs Market in Asia-Pacific by Route of Administration: Estimates and Projections in US$ Million for the Period 2020-2027
Asia-Pacific MRSA Drugs Historic Market Scenario in US$ Million by Route of Administration: 2012-2019
Asia-Pacific MRSA Drugs Market Share Analysis by Route of Administration: 2012 VS 2020 VS 2027
REST OF WORLD
Rest of World MRSA Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2020 to 2027
Rest of World MRSA Drugs Historic Market Review by Drug Class in US$ Million: 2012-2019
MRSA Drugs Market in Rest of World: Percentage Share Breakdown of Sales by Drug Class for 2012, 2020, and 2027
Rest of World MRSA Drugs Market Estimates and Forecasts in US$ Million by Route of Administration: 2020 to 2027
Rest of World MRSA Drugs Historic Market Review by Route of Administration in US$ Million: 2012-2019
MRSA Drugs Market in Rest of World: Percentage Share Breakdown of Sales by Route of Administration for 2012, 2020, and 2027
Total Companies Profiled : 27

Click here to request a full table of contents and more details on this project.

INSIDER ACCESS TO

 METHODOLOGY  QUESTIONNAIRE  INFLUENCER NETWORK

Registration is required to access our data stacks.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

  • Complimentary previews of full stack research data for participated
  • Insider access to research programs including engagements and stats from other panelists
  • Unlimited research credits of $1000 per participated project
  • Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
  • Interact with other panelists via our MarketGlassTM Data Exchange Platform*
  • BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

* Complete details will be shared with panelists upon formal acceptance.

 GLOBAL EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com

General queries: Info411@StrategyR.com